Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alexion Pharmaceuticals Inc

+ Add to Watchlist

ALXN:US

180.3700 USD 2.7400 1.50%

As of 17:20:00 ET on 02/27/2015.

Company Profile for Alexion Pharmaceuticals Inc (ALXN)

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.

Contact Information

Alexion Pharmaceuticals Inc

352 Knotter Drive
Cheshire, CT 06410
United States
Phone: 1-203-272-2596
Fax: 1-203-271-8198

Key Executives for Alexion Pharmaceuticals Inc (ALXN)

Leonard Bell "Lenny"CEO/Treasurer/Co-FounderDavid L HallalChief Operating Officer
Vikas SinhaExec VP/CFOSaqib IslamExec VP/Chief Strategy Ofcr/Portfolio Mgr
Clare CarmichaelExec VP/Chief Human Resource OfcrJohn B Moriarty JrExec VP/General Counsel
Martin MackayExec VP/Head:Research & DevJulie O'NeillExec VP:Global Ops
Edward MillerSenior VP/Chief Compliance OfcrElena RidloffExec Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil